Page last updated: 2024-08-21

diphenylamine and everolimus

diphenylamine has been researched along with everolimus in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anderson, LK; Collins, MH; Greeley, AD; Halfond, AL; Keng, VW; Largaespada, DA; Moertel, CL; Powell, NM; Rahrmann, EP; Ratner, N; Rizvi, T; Watson, AL	1
Bekki, H; Ishii, T; Iura, K; Iwamoto, Y; Kawashima, H; Kohashi, K; Maekawa, A; Nabeshima, K; Oda, Y; Yamada, Y; Yamamoto, H	1

Other Studies

2 other study(ies) available for diphenylamine and everolimus

Article	Year
Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. Oncotarget, 2014, Mar-30, Volume: 5, Issue:6 Topics: Animals; Apoptosis; Benzamides; Blotting, Western; Cell Proliferation; Cells, Cultured; Diphenylamine; Disease Models, Animal; Drug Synergism; Everolimus; Fluorescent Antibody Technique; Humans; Immunoenzyme Techniques; Immunosuppressive Agents; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinases; Neoplasm Grading; Neurilemmoma; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Schwann Cells; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases	2014
Activation of the Akt-mTOR and MAPK pathways in dedifferentiated liposarcomas. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016, Volume: 37, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Cell Proliferation; Diphenylamine; Drug Synergism; Everolimus; Female; Humans; Inhibitory Concentration 50; Liposarcoma; Male; MAP Kinase Signaling System; Middle Aged; TOR Serine-Threonine Kinases	2016

Article

Year

Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity.

Oncotarget, 2014, Mar-30, Volume: 5, Issue:6

Topics: Animals; Apoptosis; Benzamides; Blotting, Western; Cell Proliferation; Cells, Cultured; Diphenylamine; Disease Models, Animal; Drug Synergism; Everolimus; Fluorescent Antibody Technique; Humans; Immunoenzyme Techniques; Immunosuppressive Agents; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinases; Neoplasm Grading; Neurilemmoma; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Schwann Cells; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases

2014

Activation of the Akt-mTOR and MAPK pathways in dedifferentiated liposarcomas.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016, Volume: 37, Issue:4

Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Cell Proliferation; Diphenylamine; Drug Synergism; Everolimus; Female; Humans; Inhibitory Concentration 50; Liposarcoma; Male; MAP Kinase Signaling System; Middle Aged; TOR Serine-Threonine Kinases

2016